Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The China Biotechnology Directory 2025 is an indispensable resource for navigating the fast-growing Chinese biotech market. With thousands of up-to-date company profiles, executive contacts, and ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

The Group closed the 2024 financial year with a net loss of EUR 12.8 million, as reflected in the newly published annual financial statements. Based on current planning, the Company expects a net loss ...

A new AI IVF system has helped give birth to a healthy baby boy for the first time, and many hope it will make IVF more ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

The "Medical Gas Market Size, Share & Trends Analysis Report By Product (Pure Gases, Gas Mixtures), By Application (Therapeutic), By End Use (Hospitals, Ambulatory Surgical Centers, Home Healthcare, ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, and nuclear research, where controlled environments are essential. Rising ...

Forecasts show cancer's global footprint expanding sharply, with annual case counts expected to rise 20% by 2030 and swell by ...